Ioannis Tarnanas - Worldwebforum
2018 EIT Innovators Award Winner Ioannis Tarnanas | EIT
Vote here for EIT Health's nominees to the EIT Public Award - EIT Health
Altoida Raises $6.3 Million for Early, AI-Test for Alzheimer's Disease
The power to innovate: winners of EIT Awards 2018 announced | EIT
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
GBHI Team Receive Multiple Awards for Driving Progress in Dementia Prevention and Care | Global Brain Health Institute
ADDF Awards $15 Million in New Investments Supporting Wide Range of Innovative Alzheimer's Research | Alzheimer's Drug Discovery Foundation
EIT Health wins 3 of 5 top European awards for innovations to treat cancer, predict Alzheimer's and detect stroke risk - EIT Health
Ioannis Tarnanas - Έλληνας ερευνητής κέρδισε ΕΙΤ Innovators Award | ellines.com
Ioannis Tarnanas (@ITarnanas) / Twitter
Greek Researcher Receives Top European Innovation Award
Altoida Awarded FDA Breakthrough Designation for Development of World's First Precision Neurology Device for Prediction of Alzheimer's Disease
EIT Health - Ioannis Tarnanas is the winner of #EIT Innovators Award. He is CSO for Altoida- makers of ADPS, which can tell if someone will develop Alzheimer's disease within 6 years,
Ioannis Tarnanas (@ITarnanas) / Twitter
Hamid Sohrabi (my views) (@HamidRSohrabi) / Twitter
Impact Hub Zürich - Ioannis Tarnanas is Impact Hub Fellow on Healthy Living. frederike asael photography | Facebook
Ioannis Tarnanas - Worldwebforum
Ioannis Tarnanas - Worldwebforum
Ioannis Tarnanas - Worldwebforum
EIT Health - Congratulations to Altoida for raising $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality. Altoida CSO – Dr. Ioannis Tarnanas was the
The European Institute of Innovation and Technology (EIT) announces winners of the 2018 EIT Awards on 10th anniversary - Business Review
